Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Pediatr Dermatol ; 35(5): e272-e275, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29962053

RESUMO

Neonatal blue-light phototherapy induced a blistering reaction followed by eruption of melanocytic nevi on the exposed skin surface of a child with transient neonatal porphyrinemia. New nevi are still developing 4 years after the triggering event. The role of phototoxicity-induced epidermal injury, that of porphyrins and the influence of neonatal blue-light therapy, in this unique phenomenon are discussed.


Assuntos
Dermatite Fototóxica/etiologia , Nevo Pigmentado/etiologia , Fototerapia/efeitos adversos , Porfirinas/sangue , Neoplasias Cutâneas/etiologia , Vesícula/etiologia , Humanos , Lactente , Recém-Nascido , Masculino , Nevo Pigmentado/patologia , Pele/patologia , Neoplasias Cutâneas/patologia
2.
Crit Care Med ; 36(7): 2117-27, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18594222

RESUMO

OBJECTIVE: Intraperitoneal administration of large doses of L-arginine is known to induce severe acute pancreatitis in rats. We therefore set out to determine whether metabolites of L-arginine (L-ornithine, L-citrulline, and nitric oxide) cause pancreatitis. DESIGN: The authors conducted an in vivo animal study. SETTING: This study was conducted at a university research laboratory. SUBJECTS: Study subjects were male Wistar rats. INTERVENTIONS: Dose-response and time course changes of laboratory and histologic parameters of pancreatitis were determined after L-arginine, L-ornithine, L-citrulline, or sodium nitroprusside (nitric oxide donor) injection. MEASUREMENTS AND MAIN RESULTS: Intraperitoneal injection of 3 g/kg L-ornithine but not L-citrulline or nitroprusside caused severe acute pancreatitis; 4 to 6 g/kg L-ornithine killed the animals within hours. Serum and ascitic amylase activities were significantly increased, whereas pancreatic amylase activity was decreased after intraperitoneal injection of 3 g/kg L-ornithine. The increase in pancreatic trypsin activity (9-48 hrs) correlated with the degradation of IkappaB proteins and elevated interleukin-1beta levels. Oxidative stress in the pancreas was evident from 6 hrs; HSP72 synthesis was increased from 4 hrs after L-ornithine administration. Morphologic examination of the pancreas showed massive interstitial edema, apoptosis, and necrosis of acinar cells and infiltration of neutrophil granulocytes and monocytes 18 to 36 hrs after 3 g/kg L-ornithine injection. One month after L-ornithine injection, the pancreas appeared almost normal; the destructed parenchyma was partly replaced by fat. Equimolar administration of L-arginine resulted in lower pancreatic weight/body weight ratio, pancreatic myeloperoxidase activity, and histologic damage compared with the L-ornithine-treated group. L-ornithine levels in the blood were increased 54-fold after intraperitoneal administration of L-arginine. CONCLUSIONS: We have developed a simple, noninvasive model of acute necrotizing pancreatitis in rats by intraperitoneal injection of 3 g/kg L-ornithine. Interestingly, we found that, compared with L-arginine, L-ornithine was even more effective at inducing pancreatitis. Large doses of L-arginine produce a toxic effect on the pancreas, at least in part, through L-ornithine.


Assuntos
Ornitina/toxicidade , Pancreatite Necrosante Aguda/induzido quimicamente , Animais , Apoptose/efeitos dos fármacos , Arginina/sangue , Arginina/toxicidade , Citrulina/sangue , Citrulina/toxicidade , Relação Dose-Resposta a Droga , Injeções Intraperitoneais , Masculino , Ornitina/administração & dosagem , Ornitina/sangue , alfa-Amilases Pancreáticas , Pancreatite Necrosante Aguda/metabolismo , Pancreatite Necrosante Aguda/patologia , Peroxidase/metabolismo , Ratos , Ratos Wistar , Fatores de Tempo , Tripsina/metabolismo , alfa-Amilases/metabolismo
3.
Eur J Pharmacol ; 571(2-3): 120-8, 2007 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-17597609

RESUMO

Alpha-tocopherol, a potent antioxidant, has been widely investigated as a dietary supplement with which to reduce the risk of atherosclerosis, and has recently been considered as a potential supplement to moderate oxidative neuronal damage in Alzheimer's disease patients. Since alpha-tocopherol appears beneficial in vascular and neurodegenerative disorders, we set out to identify its neuroprotective action in a rat model of chronic cerebral hypoperfusion-induced brain injury. The bilateral common carotid arteries of male Wistar rats were permanently occluded (2VO). Sham-operated animals served as controls. Half of the animals were pre- or post-treated repeatedly with alpha-tocopherol (5x100 mg/kg daily, i.p.), the other half receiving only soybean oil, the alpha-tocopherol vehicle. One week after the onset of 2VO, the spatial learning capacity of the animals was assessed in the Morris water maze. After testing, hippocampal slices were stained with cresyl violet in order to examine the pyramidal cell layer integrity. The density of microtubule-associated protein-2 (MAP-2)-positive dendrites and the OX-42-labeled microglial activation level were determined immunocytochemically. Finally, alpha-tocopherol was determined in the peripheral tissues, blood and brain. Alpha-tocopherol moderated the 2VO-induced learning impairment. The various forms of alpha-tocopherol treatment, and particularly the post-treatment, prevented the 2VO-induced pyramidal cell death and the activation of microglia in the hippocampus CA1 region, and the degeneration of MAP-2-positive dendrites in the CA3 region. The alpha-tocopherol concentration was elevated in the peripheral tissues and the blood, but not in the brain. The data indicate that alpha-tocopherol, particularly when administered as post-treatment, is neuroprotective in chronic cerebral hypoperfusion.


Assuntos
Isquemia Encefálica/prevenção & controle , Circulação Cerebrovascular , Hipocampo/efeitos dos fármacos , Degeneração Neural/prevenção & controle , Neurônios/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , alfa-Tocoferol/farmacologia , Animais , Comportamento Animal/efeitos dos fármacos , Isquemia Encefálica/metabolismo , Isquemia Encefálica/patologia , Isquemia Encefálica/fisiopatologia , Artéria Carótida Primitiva/cirurgia , Morte Celular/efeitos dos fármacos , Doença Crônica , Dendritos/efeitos dos fármacos , Dendritos/patologia , Modelos Animais de Doenças , Esquema de Medicação , Hipocampo/irrigação sanguínea , Hipocampo/metabolismo , Hipocampo/patologia , Aprendizagem/efeitos dos fármacos , Ligadura , Masculino , Microglia/efeitos dos fármacos , Microglia/patologia , Proteínas Associadas aos Microtúbulos/metabolismo , Degeneração Neural/metabolismo , Degeneração Neural/patologia , Degeneração Neural/fisiopatologia , Neurônios/metabolismo , Neurônios/patologia , Fármacos Neuroprotetores/administração & dosagem , Fármacos Neuroprotetores/metabolismo , Fármacos Neuroprotetores/uso terapêutico , Células Piramidais/efeitos dos fármacos , Células Piramidais/patologia , Ratos , Ratos Wistar , Percepção Espacial/efeitos dos fármacos , Distribuição Tecidual , alfa-Tocoferol/administração & dosagem , alfa-Tocoferol/metabolismo , alfa-Tocoferol/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA